Search Results 991-1000 of 15364 for alt

  1. Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer - Mayo Clinic

    ≤ 1.2 x upper limit of normal (ULN)**. AST and ALT. ≤ 2.5 x upper limit of normal (ULN). * Calculated using the Cockcroft-Gault formula. **Unless due to ...

  2. Alcoholic Hepatitis: A Multicenter, Observational Study by the TREAT Consortium - Mayo Clinic

    AST and ALT ≤ 50 and total bilirubin levels within normal range. If bilirubin is increased due to a suspected Gilbert's Syndrome, patient may be enrolled ...

  3. Clinical Trials - FT576 in Subjects With Multiple Myeloma

    - AST > 3 x ULN or ALT > 3 x ULN, unless directly due to underlying malignancy. - O2 sat < 92% on room air. Clinically significant cardiovascular disease ...

  4. Long-term Safety Study Of Chronocort In The Treatment Of Participants With Congenital Adrenal Hyperplasia - Mayo Clinic

    (alanine aminotransferase [ALT] or aspartate aminotransferase [AST] > 2 times the ULN). - Participants with a history of malignancy (other than basal cell ...

  5. Study to Assess the Safety and Effectiveness of Oral BTD-001 in Adults with Idiopathic Hypersomnia - Mayo Clinic

    Significant hepatic impairment (ALT, AST or total bilirubin > 1.5 × ULN);; Renal impairment (estimated creatinine clearance <50 mL/min by Cockcroft Gault).

  6. Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203) - Mayo Clinic

    Liver function: total bilirubin < 1.5 x the upper limit of normal and alanine aminotransferase (ALT)/aspartate aminotransferase (AST) < 2.5x the upper normal ...

  7. Oligomets pancreas SBRT - Mayo Clinic

    Alanine aminotransferase (ALT) and aspartate transaminase (AST) ≤ 3 x ULN (≤ 5 x ULN for patients with liver involvement);; PT/INR/aPTT ≤ 1.5 x ULN OR if ...

  8. Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer - Mayo Clinic

    ALT and AST ≤2.5 x ULN or ≤5 x ULN if liver metastases are present. Total bilirubin ≤ 1. 5 x ULN. Standard 12-lead ECG with the following parameters at ...

  9. A Study To Evaluate APG2575 Combined With Novel Therapeutic Regimens To Treat Subjects With Relapsed Or Refractory Multiple Myeloma And Immunoglobulin Light Chain Amyloidosis - Mayo Clinic

    AST and ALT < 3 x ULN (upper limit of normal);; Creatinine clearance > 30mL/min;; Bilirubin< 1.5 x ULN (Except if considered secondary to Gilbert's syndrome ...

  10. Temozolomide With or Without Veliparib in Treating Patients With Newly Diagnosed Glioblastoma Multiforme - Mayo Clinic

    Alanine aminotransferase (ALT) ≤ 3 x ULN; Aspartate aminotransferase (AST) ≤ 3 x ULN; Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2 ...